{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:40:07Z","timestamp":1790260807577,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fondation pour Recherche Mediacle","award":["Team"],"award-info":[{"award-number":["Team"]}]},{"name":"Agence National pour la Recherche","award":["ANR-18-CE14-0030-01"],"award-info":[{"award-number":["ANR-18-CE14-0030-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00467-020-04475-w","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T10:02:57Z","timestamp":1581328977000},"page":"497-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["New therapeutic perspectives for IgA nephropathy in children"],"prefix":"10.1007","volume":"36","author":[{"given":"Alexandra","family":"Cambier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9loise","family":"Flament","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-B\u00e9n\u00e9dicte","family":"Le Stang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5202-5646","authenticated-orcid":false,"given":"Renato C.","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"4475_CR1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/oxfordjournals.ndt.a027821","volume":"13","author":"R Coppo","year":"1998","unstructured":"Coppo R, Gianoglio B, Porcellini MG, Maringhini S (1998) Frequency of renal diseases and clinical indications for renal biopsy in children (report of the Italian National Registry of renal biopsies in children). Group of Renal Immunopathology of the Italian Society of Pediatric Nephrology. Nephrol Dial Transplant 13:293\u2013297","journal-title":"Nephrol Dial Transplant"},{"key":"4475_CR2","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.molmed.2015.10.003","volume":"21","author":"T Robert","year":"2015","unstructured":"Robert T, Berthelot L, Cambier A, Rondeau E, Monteiro RC (2015) Molecular insights into the pathogenesis of IgA nephropathy. Trends Mol Med 21:762\u2013775","journal-title":"Trends Mol Med"},{"key":"4475_CR3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","volume":"76","author":"DC Cattran","year":"2009","unstructured":"Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D\u2019Agati V, D\u2019Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534\u2013545","journal-title":"Kidney Int"},{"key":"4475_CR4","doi-asserted-by":"crossref","first-page":"e0150885","DOI":"10.1371\/journal.pone.0150885","volume":"11","author":"K Kamei","year":"2016","unstructured":"Kamei K, Harada R, Hamada R, Sakai T, Hamasaki Y, Hataya H, Ito S, Ishikura K, Honda M (2016) Proteinuria during follow-up period and long-term renal survival of childhood IgA nephropathy. PLoS One 11:e0150885","journal-title":"PLoS One"},{"key":"4475_CR5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40620-016-0360-z","volume":"30","author":"R Coppo","year":"2017","unstructured":"Coppo R (2017) Clinical and histological risk factors for progression of IgA nephropathy: an update in children, young and adult patients. J Nephrol 30:339\u2013346","journal-title":"J Nephrol"},{"key":"4475_CR6","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.2016091043","volume":"28","author":"DP Gale","year":"2017","unstructured":"Gale DP, Molyneux K, Wimbury D, Higgins P, Levine AP, Caplin B, Ferlin A, Yin P, Nelson CP, Stanescu H, Samani NJ, Kleta R, Yu X, Barratt J (2017) Galactosylation of IgA1 is associated with common variation in C1GALT1. J Am Soc Nephrol 28:2158\u20132166","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2369-5-10","volume":"5","author":"YN Hall","year":"2004","unstructured":"Hall YN, Fuentes EF, Chertow GM, Olson JL (2004) Race\/ethnicity and disease severity in IgA nephropathy. BMC Nephrol 5:10","journal-title":"BMC Nephrol"},{"key":"4475_CR8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0272-6386(97)90333-4","volume":"29","author":"A Koyama","year":"1997","unstructured":"Koyama A, Igarashi M, Kobayashi M (1997) Natural history and risk factors for immunoglobulin a nephropathy in Japan. Research group on progressive renal diseases. Am J Kidney Dis 29:526\u2013532","journal-title":"Am J Kidney Dis"},{"key":"4475_CR9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0022-3476(95)70027-7","volume":"127","author":"RJ Wyatt","year":"1995","unstructured":"Wyatt RJ, Kritchevsky SB, Woodford SY, Miller PM, Roy S 3rd, Holland NH, Jackson E, Bishof NA (1995) IgA nephropathy: long-term prognosis for pediatric patients. J Pediatr 127:913\u2013919","journal-title":"J Pediatr"},{"key":"4475_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1681\/ASN.V82199","volume":"8","author":"MG Radford Jr","year":"1997","unstructured":"Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP (1997) Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8:199\u2013207","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00467-006-0303-3","volume":"22","author":"MC Hastings","year":"2007","unstructured":"Hastings MC, Delos Santos NM, Wyatt RJ (2007) Renal survival in pediatric patients with IgA nephropathy. Pediatr Nephrol 22:317\u2013318","journal-title":"Pediatr Nephrol"},{"key":"4475_CR12","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/s00467-006-0163-x","volume":"21","author":"J Ronkainen","year":"2006","unstructured":"Ronkainen J, Ala-Houhala M, Autio-Harmainen H, Jahnukainen T, Koskimies O, Merenmies J, Mustonen J, Ormala T, Turtinen J, Nuutinen M (2006) Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study. Pediatr Nephrol 21:1266\u20131273","journal-title":"Pediatr Nephrol"},{"key":"4475_CR13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00467-012-2139-3","volume":"27","author":"T Wang","year":"2012","unstructured":"Wang T, Ye F, Meng H, Zhang L, Jin X (2012) Comparison of clinicopathological features between children and adults with IgA nephropathy. Pediatr Nephrol 27:1293\u20131300","journal-title":"Pediatr Nephrol"},{"key":"4475_CR14","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/ndt\/gfn014","volume":"23","author":"M Haas","year":"2008","unstructured":"Haas M, Rahman MH, Cohn RA, Fathallah-Shaykh S, Ansari A, Bartosh SM (2008) IgA nephropathy in children and adults: comparison of histologic features and clinical outcomes. Nephrol Dial Transplant 23:2537\u20132545","journal-title":"Nephrol Dial Transplant"},{"key":"4475_CR15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00467-014-2862-z","volume":"30","author":"Y Shima","year":"2015","unstructured":"Shima Y, Nakanishi K, Hama T, Sato M, Mukaiyama H, Togawa H, Tanaka R, Kaito H, Nozu K, Iijima K, Yoshikawa N (2015) Biopsy timing and Oxford classification variables in childhood\/adolescent IgA nephropathy. Pediatr Nephrol 30:293\u2013299","journal-title":"Pediatr Nephrol"},{"key":"4475_CR16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/01.ASN.0000115401.07980.0C","volume":"15","author":"IC Moura","year":"2004","unstructured":"Moura IC, Arcos-Fajardo M, Sadaka C, Leroy V, Benhamou M, Novak J, Vrtovsnik F, Haddad E, Chintalacharuvu KR, Monteiro RC (2004) Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 15:622\u2013634","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR17","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1172\/JCI74475","volume":"124","author":"K Kiryluk","year":"2014","unstructured":"Kiryluk K, Novak J (2014) The genetics and immunobiology of IgA nephropathy. J Clin Invest 124:2325\u20132332","journal-title":"J Clin Invest"},{"key":"4475_CR18","doi-asserted-by":"crossref","first-page":"315467","DOI":"10.1155\/2012\/315467","volume":"2012","author":"MC Hastings","year":"2012","unstructured":"Hastings MC, Afshan S, Sanders JT, Kane O, Eison TM, Lau KK, Moldoveanu Z, Julian BA, Novak J, Wyatt RJ (2012) Serum galactose-deficient IgA1 level is not associated with proteinuria in children with IgA nephropathy. Int J Nephrol 2012:315467","journal-title":"Int J Nephrol"},{"key":"4475_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ki.2011.16","volume":"80","author":"K Kiryluk","year":"2011","unstructured":"Kiryluk K, Moldoveanu Z, Sanders JT, Eison TM, Suzuki H, Julian BA, Novak J, Gharavi AG, Wyatt RJ (2011) Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch\u2013Schonlein purpura nephritis. Kidney Int 80:79\u201387","journal-title":"Kidney Int"},{"key":"4475_CR20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5114\/ceji.2018.77386","volume":"43","author":"M Mizerska-Wasiak","year":"2018","unstructured":"Mizerska-Wasiak M, Gajewski L, Cichon-Kawa K, Maldyk J, Dziedzic-Jankowska K, Leszczynska B, Rybi-Szuminska A, Wasilewska A, Pukajlo-Marczyk A, Zwolinska D, Bienias B, Sikora P, Szczepanska M, Stelmaszczyk-Emmel A, Gorska E, Panczyk-Tomaszewska M (2018) Serum GDIgA1 levels in children with IgA nephropathy and Henoch\u2013Schonlein nephritis. Cent Eur J Immunol 43:162\u2013167","journal-title":"Cent Eur J Immunol"},{"key":"4475_CR21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1517\/14712598.2015.1006624","volume":"15","author":"Y Suzuki","year":"2015","unstructured":"Suzuki Y, Suzuki H, Yasutake J, Tomino Y (2015) Paradigm shift in activity assessment of IgA nephropathy\u2014optimizing the next generation of diagnostic and therapeutic maneuvers via glycan targeting. Expert Opin Biol Ther 15:583\u2013593","journal-title":"Expert Opin Biol Ther"},{"key":"4475_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2353\/ajpath.2008.070131","volume":"172","author":"ME Lamm","year":"2008","unstructured":"Lamm ME, Emancipator SN, Robinson JK, Yamashita M, Fujioka H, Qiu J, Plaut AG (2008) Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy. Am J Pathol 172:31\u201336","journal-title":"Am J Pathol"},{"key":"4475_CR23","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1681\/ASN.2015080856","volume":"27","author":"SM Lechner","year":"2016","unstructured":"Lechner SM, Abbad L, Boedec E, Papista C, Le Stang MB, Moal C, Maillard J, Jamin A, Bex-Coudrat J, Wang Y, Li A, Martini PG, Monteiro RC, Berthelot L (2016) IgA1 protease treatment reverses mesangial deposits and hematuria in a model of IgA nephropathy. J Am Soc Nephrol 27:2622\u20132629","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR24","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/ndt\/gfq115","volume":"25","author":"R Yang","year":"2010","unstructured":"Yang R, Otten MA, Hellmark T, Collin M, Bjorck L, Zhao MH, Daha MR, Segelmark M (2010) Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes. Nephrol Dial Transplant 25:2479\u20132486","journal-title":"Nephrol Dial Transplant"},{"key":"4475_CR25","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.kint.2019.06.019","volume":"96","author":"I Soveri","year":"2019","unstructured":"Soveri I, Molne J, Uhlin F, Nilsson T, Kjellman C, Sonesson E, Segelmark M (2019) The IgG-degrading enzyme of Streptococcus pyogenes causes rapid clearance of anti-glomerular basement membrane antibodies in patients with refractory anti-glomerular basement membrane disease. Kidney Int 96:1234\u20131238","journal-title":"Kidney Int"},{"key":"4475_CR26","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00467-015-3176-5","volume":"30","author":"A Higa","year":"2015","unstructured":"Higa A, Shima Y, Hama T, Sato M, Mukaiyama H, Togawa H, Tanaka R, Nozu K, Sako M, Iijima K, Nakanishi K, Yoshikawa N (2015) Long-term outcome of childhood IgA nephropathy with minimal proteinuria. Pediatr Nephrol 30:2121\u20132127","journal-title":"Pediatr Nephrol"},{"key":"4475_CR27","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2006040347","volume":"18","author":"R Coppo","year":"2007","unstructured":"Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linne T (2007) IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 18:1880\u20131888","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0272-6386(12)80031-X","volume":"21","author":"R Coppo","year":"1993","unstructured":"Coppo R, Amore A, Gianoglio B, Cacace G, Picciotto G, Roccatello D, Peruzzi L, Piccoli G, De Filippi PG (1993) Angiotensin II local hyperreactivity in the progression of IgA nephropathy. Am J Kidney Dis 21:593\u2013602","journal-title":"Am J Kidney Dis"},{"key":"4475_CR29","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1097\/01.ASN.0000095639.56212.BF","volume":"14","author":"KN Lai","year":"2003","unstructured":"Lai KN, Tang SC, Guh JY, Chuang TD, Lam MF, Chan LY, Tsang AW, Leung JC (2003) Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin\u2013angiotensin system. J Am Soc Nephrol 14:3127\u20133137","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1479-5876-9-169","volume":"9","author":"JC Leung","year":"2011","unstructured":"Leung JC, Chan LY, Tang SC, Lam MF, Chow CW, Lim AI, Lai KN (2011) Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone. J Transl Med 9:169","journal-title":"J Transl Med"},{"key":"4475_CR31","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.25011\/cim.v32i1.5083","volume":"32","author":"ZC Ye","year":"2009","unstructured":"Ye ZC, Wang C, Tang Y, Liu X, Peng H, Zhang H, Lou TQ (2009) Serum IgA1 from patients with IgA nephropathy up-regulates integrin-linked kinase synthesis and inhibits adhesive capacity in podocytes through indirect pathways. Clin Invest Med 32:E20\u2013E27","journal-title":"Clin Invest Med"},{"key":"4475_CR32","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/ndt\/gfr612","volume":"27","author":"B Zhang","year":"2012","unstructured":"Zhang B, Xie S, Shi W, Yang Y (2012) Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria. Nephrol Dial Transplant 27:1746\u20131755","journal-title":"Nephrol Dial Transplant"},{"key":"4475_CR33","first-page":"103","volume":"2","author":"H Trimarchi","year":"2013","unstructured":"Trimarchi H (2013) Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptor. World J Nephrol 2:103\u2013110","journal-title":"World J Nephrol"},{"key":"4475_CR34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","volume":"14","author":"C Wei","year":"2008","unstructured":"Wei C, Moller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, Xie L, Henger A, Schmid H, Rastaldi MP, Cowan P, Kretzler M, Parrilla R, Bendayan M, Gupta V, Nikolic B, Kalluri R, Carmeliet P, Mundel P, Reiser J (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14:55\u201363","journal-title":"Nat Med"},{"key":"4475_CR35","doi-asserted-by":"publisher","unstructured":"Trimarchi H, Coppo R (2019) Podocytopathy in the mesangial proliferative immunoglobulin a nephropathy: new insights into the mechanisms of damage and progression. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfy413","DOI":"10.1093\/ndt\/gfy413"},{"key":"4475_CR36","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD). Kidney Int Suppl (113):S1\u2013130"},{"key":"4475_CR37","doi-asserted-by":"publisher","unstructured":"Cambier A, Boyer O, Deschenes G, Gleeson J, Couderc A, Hogan J, Robert T (2019) Steroid therapy in children with IgA nephropathy. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-018-4189-7","DOI":"10.1007\/s00467-018-4189-7"},{"key":"4475_CR38","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ekir.2018.03.013","volume":"3","author":"A Cambier","year":"2018","unstructured":"Cambier A, Rabant M, Peuchmaur M, Hertig A, Deschenes G, Couchoud C, Kolko A, Salomon R, Hogan J, Robert T (2018) Immunosuppressive treatment in children with IgA nephropathy and the clinical value of podocytopathic features. Kidney Int Rep 3:916\u2013925","journal-title":"Kidney Int Rep"},{"key":"4475_CR39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000487265","volume":"4","author":"R Coppo","year":"2018","unstructured":"Coppo R (2018) IgA nephropathy: a European perspective in the corticosteroid treatment. Kidney Dis (Basel) 4:58\u201364","journal-title":"Kidney Dis (Basel)"},{"key":"4475_CR40","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1681\/ASN.2012010053","volume":"23","author":"F Berthoux","year":"2012","unstructured":"Berthoux F, Suzuki H, Thibaudin L, Yanagawa H, Maillard N, Mariat C, Tomino Y, Julian BA, Novak J (2012) Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy. J Am Soc Nephrol 23:1579\u20131587","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR41","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ki.2012.197","volume":"82","author":"N Zhao","year":"2012","unstructured":"Zhao N, Hou P, Lv J, Moldoveanu Z, Li Y, Kiryluk K, Gharavi AG, Novak J, Zhang H (2012) The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression. Kidney Int 82:790\u2013796","journal-title":"Kidney Int"},{"key":"4475_CR42","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1681\/ASN.2016060640","volume":"28","author":"RA Lafayette","year":"2017","unstructured":"Lafayette RA, Canetta PA, Rovin BH, Appel GB, Novak J, Nath KA, Sethi S, Tumlin JA, Mehta K, Hogan M, Erickson S, Julian BA, Leung N, Enders FT, Brown R, Knoppova B, Hall S, Fervenza FC (2017) A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction. J Am Soc Nephrol 28:1306\u20131313","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR43","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1182\/blood-2010-01-266536","volume":"116","author":"HE Mei","year":"2010","unstructured":"Mei HE, Frolich D, Giesecke C, Loddenkemper C, Reiter K, Schmidt S, Feist E, Daridon C, Tony HP, Radbruch A, Dorner T (2010) Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab. Blood 116:5181\u20135190","journal-title":"Blood"},{"key":"4475_CR44","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1172\/JCI45563","volume":"121","author":"DD McCarthy","year":"2011","unstructured":"McCarthy DD, Kujawa J, Wilson C, Papandile A, Poreci U, Porfilio EA, Ward L, Lawson MA, Macpherson AJ, McCoy KD, Pei Y, Novak L, Lee JY, Julian BA, Novak J, Ranger A, Gommerman JL, Browning JL (2011) Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. J Clin Invest 121:3991\u20134002","journal-title":"J Clin Invest"},{"key":"4475_CR45","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jgm.2966","volume":"19","author":"Z Zhong","year":"2017","unstructured":"Zhong Z, Feng SZ, Xu RC, Li ZJ, Huang FX, Yin PR, Liu WT, Wang M, Shi DC, Zhou Q, Yu XQ, Li M (2017) Association of TNFSF13 polymorphisms with IgA nephropathy in a Chinese Han population. J Gene Med 19:6\u20137","journal-title":"J Gene Med"},{"key":"4475_CR46","doi-asserted-by":"crossref","first-page":"e3099","DOI":"10.1097\/MD.0000000000003099","volume":"95","author":"YL Zhai","year":"2016","unstructured":"Zhai YL, Zhu L, Shi SF, Liu LJ, Lv JC, Zhang H (2016) Increased APRIL expression induces IgA1 aberrant glycosylation in IgA nephropathy. Medicine (Baltimore) 95:e3099","journal-title":"Medicine (Baltimore)"},{"key":"4475_CR47","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3892\/mmr.2014.2359","volume":"10","author":"W Li","year":"2014","unstructured":"Li W, Peng X, Liu Y, Liu H, Liu F, He L, Liu Y, Zhang F, Guo C, Chen G, Zhang L, Dong Z, Peng Y (2014) TLR9 and BAFF: their expression in patients with IgA nephropathy. Mol Med Rep 10:1469\u20131474","journal-title":"Mol Med Rep"},{"key":"4475_CR48","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00431-014-2287-5","volume":"173","author":"R Luo","year":"2014","unstructured":"Luo R, Liu W, Wang J, Chen Y, Sun C, Zhou L, Li Y, Deng L (2014) Role of BAFF in pediatric patients with allergic rhinitis during sublingual immunotherapy. Eur J Pediatr 173:1033\u20131040","journal-title":"Eur J Pediatr"},{"key":"4475_CR49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.5301\/jn.5000218","volume":"26","author":"G Xin","year":"2013","unstructured":"Xin G, Shi W, Xu LX, Su Y, Yan LJ, Li KS (2013) Serum BAFF is elevated in patients with IgA nephropathy and associated with clinical and histopathological features. J Nephrol 26:683\u2013690","journal-title":"J Nephrol"},{"key":"4475_CR50","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.kint.2019.01.031","volume":"96","author":"JR Myette","year":"2019","unstructured":"Myette JR, Kano T, Suzuki H, Sloan SE, Szretter KJ, Ramakrishnan B, Adari H, Deotale KD, Engler F, Shriver Z, Wollacott AM, Suzuki Y, Pereira BJG (2019) A proliferation inducing ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy. Kidney Int 96:104\u2013116","journal-title":"Kidney Int"},{"key":"4475_CR51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3389\/fphys.2017.00508","volume":"8","author":"W Gao","year":"2017","unstructured":"Gao W, Xiong Y, Li Q, Yang H (2017) Inhibition of Toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nano therapeutics. Front Physiol 8:508","journal-title":"Front Physiol"},{"key":"4475_CR52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000487330","volume":"47","author":"YZ Yang","year":"2018","unstructured":"Yang YZ, Liu LJ, Shi SF, Wang JW, Chen YQ, Lv JC, Zhang H (2018) Effects of hydroxychloroquine on proteinuria in immunoglobulin a nephropathy. Am J Nephrol 47:145\u2013152","journal-title":"Am J Nephrol"},{"key":"4475_CR53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.ajkd.2019.01.026","volume":"74","author":"LJ Liu","year":"2019","unstructured":"Liu LJ, Yang YZ, Shi SF, Bao YF, Yang C, Zhu SN, Sui GL, Chen YQ, Lv JC, Zhang H (2019) Effects of hydroxychloroquine on proteinuria in IgA nephropathy: a randomized controlled trial. Am J Kidney Dis 74:15\u201322","journal-title":"Am J Kidney Dis"},{"key":"4475_CR54","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/eye.2016.298","volume":"31","author":"IH Yusuf","year":"2017","unstructured":"Yusuf IH, Sharma S, Luqmani R, Downes SM (2017) Hydroxychloroquine retinopathy. Eye (Lond) 31:828\u2013845","journal-title":"Eye (Lond)"},{"key":"4475_CR55","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/ki.2008.579","volume":"75","author":"R Coppo","year":"2009","unstructured":"Coppo R, Camilla R, Alfarano A, Balegno S, Mancuso D, Peruzzi L, Amore A, Dal Canton A, Sepe V, Tovo P (2009) Upregulation of the immunoproteasome in peripheral blood mononuclear cells of patients with IgA nephropathy. Kidney Int 75:536\u2013541","journal-title":"Kidney Int"},{"key":"4475_CR56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ekir.2018.03.001","volume":"3","author":"C Hartono","year":"2018","unstructured":"Hartono C, Chung M, Perlman AS, Chevalier JM, Serur D, Seshan SV, Muthukumar T (2018) Bortezomib for reduction of proteinuria in IgA nephropathy. Kidney Int Rep 3:861\u2013866","journal-title":"Kidney Int Rep"},{"key":"4475_CR57","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.4049\/jimmunol.1102603","volume":"189","author":"MJ Kim","year":"2012","unstructured":"Kim MJ, McDaid JP, McAdoo SP, Barratt J, Molyneux K, Masuda ES, Pusey CD, Tam FW (2012) Spleen tyrosine kinase is important in the production of proinflammatory cytokines and cell proliferation in human mesangial cells following stimulation with IgA1 isolated from IgA nephropathy patients. J Immunol 189:3751\u20133758","journal-title":"J Immunol"},{"key":"4475_CR58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/ki.2015.29","volume":"88","author":"SP McAdoo","year":"2015","unstructured":"McAdoo SP, Bhangal G, Page T, Cook HT, Pusey CD, Tam FW (2015) Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression. Kidney Int 88:52\u201360","journal-title":"Kidney Int"},{"key":"4475_CR59","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1681\/ASN.2014101000","volume":"26","author":"N Maillard","year":"2015","unstructured":"Maillard N, Wyatt RJ, Julian BA, Kiryluk K, Gharavi A, Fremeaux-Bacchi V, Novak J (2015) Current understanding of the role of complement in IgA nephropathy. J Am Soc Nephrol 26:1503\u20131512","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR60","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1681\/ASN.2005090923","volume":"17","author":"A Roos","year":"2006","unstructured":"Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR (2006) Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 17:1724\u20131734","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR61","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.167.5.2861","volume":"167","author":"A Roos","year":"2001","unstructured":"Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR (2001) Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 167:2861\u20132868","journal-title":"J Immunol"},{"key":"4475_CR62","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2215\/CJN.09710913","volume":"9","author":"M Espinosa","year":"2014","unstructured":"Espinosa M, Ortega R, Sanchez M, Segarra A, Salcedo MT, Gonzalez F, Camacho R, Valdivia MA, Cabrera R, Lopez K, Pinedo F, Gutierrez E, Valera A, Leon M, Cobo MA, Rodriguez R, Ballarin J, Arce Y, Garcia B, Munoz MD, Praga M, Spanish Group for Study of Glomerular Diseases (GLOSEN) (2014) Association of C4d deposition with clinical outcomes in IgA nephropathy. Clin J Am Soc Nephrol 9:897\u2013904","journal-title":"Clin J Am Soc Nephrol"},{"key":"4475_CR63","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ki.1987.72","volume":"3","author":"EW Rauterberg","year":"1987","unstructured":"Rauterberg EW, Lieberknecht HM, Wingen AM, Ritz E (1987) Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney Int 3:820\u2013829","journal-title":"Kidney Int"},{"key":"4475_CR64","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng.787","volume":"43","author":"AG Gharavi","year":"2011","unstructured":"Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, Novak J, He JC, Wang H, Lv J, Zhu L, Wang W, Wang Z, Yasuno K, Gunel M, Mane S, Umlauf S, Tikhonova I, Beerman I, Savoldi S, Magistroni R, Ghiggeri GM, Bodria M, Lugani F, Ravani P, Ponticelli C, Allegri L, Boscutti G, Frasca G, Amore A, Peruzzi L, Coppo R, Izzi C, Viola BF, Prati E, Salvadori M, Mignani R, Gesualdo L, Bertinetto F, Mesiano P, Amoroso A, Scolari F, Chen N, Zhang H, Lifton RP (2011) Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43:321\u2013327","journal-title":"Nat Genet"},{"key":"4475_CR65","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1681\/ASN.2014010096","volume":"26","author":"L Zhu","year":"2015","unstructured":"Zhu L, Zhai YL, Wang FM, Hou P, Lv JC, Xu DM, Shi SF, Liu LJ, Yu F, Zhao MH, Novak J, Gharavi AG, Zhang H (2015) Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy. J Am Soc Nephrol 26:1195\u20131204","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.1994.tb06033.x","volume":"95","author":"ME van den Dobbelsteen","year":"1994","unstructured":"van den Dobbelsteen ME, Verhasselt V, Kaashoek JG, Timmerman JJ, Schroeijers WE, Verweij CL, van der Woude FJ, van Es LA, Daha MR (1994) Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma. Clin Exp Immunol 95:173\u2013180","journal-title":"Clin Exp Immunol"},{"key":"4475_CR67","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4049\/jimmunol.1302249","volume":"193","author":"R Schmitt","year":"2014","unstructured":"Schmitt R, Stahl AL, Olin AI, Kristoffersson AC, Rebetz J, Novak J, Lindahl G, Karpman D (2014) The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy. J Immunol 193:317\u2013326","journal-title":"J Immunol"},{"key":"4475_CR68","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/ckj\/sfv076","volume":"8","author":"T Ring","year":"2015","unstructured":"Ring T, Pedersen BB, Salkus G, Goodship TH (2015) Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum? Clin Kidney J 8:489\u2013491","journal-title":"Clin Kidney J"},{"key":"4475_CR69","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1007\/s00467-014-2863-y","volume":"29","author":"T Rosenblad","year":"2014","unstructured":"Rosenblad T, Rebetz J, Johansson M, Bekassy Z, Sartz L, Karpman D (2014) Eculizumab treatment for rescue of renal function in IgA nephropathy. Pediatr Nephrol 29:2225\u20132228","journal-title":"Pediatr Nephrol"},{"key":"4475_CR70","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10875-013-9970-6","volume":"34","author":"L Liu","year":"2014","unstructured":"Liu L, Zhang Y, Duan X, Peng Q, Liu Q, Zhou Y, Quan S, Xing G (2014) C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy. J Clin Immunol 34:224\u2013232","journal-title":"J Clin Immunol"},{"key":"4475_CR71","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10157-019-01700-1","volume":"23","author":"H Selvaskandan","year":"2019","unstructured":"Selvaskandan H, Cheung CK, Muto M, Barratt J (2019) New strategies and perspectives on managing IgA nephropathy. Clin Exp Nephrol 23:577\u2013588","journal-title":"Clin Exp Nephrol"},{"key":"4475_CR72","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","volume":"66","author":"LA McNamara","year":"2017","unstructured":"McNamara LA, Topaz N, Wang X, Hariri S, Fox L, MacNeil JR (2017) High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep 66:734\u2013737","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4475_CR73","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrneph.2015.208","volume":"12","author":"J Floege","year":"2016","unstructured":"Floege J, Feehally J (2016) The mucosa\u2013kidney axis in IgA nephropathy. Nat Rev Nephrol 12:147\u2013156","journal-title":"Nat Rev Nephrol"},{"key":"4475_CR74","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3118","volume":"46","author":"K Kiryluk","year":"2014","unstructured":"Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M, Fasel D, Lata S, Prakash S, Shapiro S, Fischman C, Snyder HJ, Appel G, Izzi C, Viola BF, Dallera N, Del Vecchio L, Barlassina C, Salvi E, Bertinetto FE, Amoroso A, Savoldi S, Rocchietti M, Amore A, Peruzzi L, Coppo R, Salvadori M, Ravani P, Magistroni R, Ghiggeri GM, Caridi G, Bodria M, Lugani F, Allegri L, Delsante M, Maiorana M, Magnano A, Frasca G, Boer E, Boscutti G, Ponticelli C, Mignani R, Marcantoni C, Di Landro D, Santoro D, Pani A, Polci R, Feriozzi S, Chicca S, Galliani M, Gigante M, Gesualdo L, Zamboli P, Battaglia GG, Garozzo M, Maixnerova D, Tesar V, Eitner F, Rauen T, Floege J, Kovacs T, Nagy J, Mucha K, Paczek L, Zaniew M, Mizerska-Wasiak M, Roszkowska-Blaim M, Pawlaczyk K, Gale D, Barratt J, Thibaudin L, Berthoux F, Canaud G, Boland A, Metzger M, Panzer U, Suzuki H, Goto S, Narita I, Caliskan Y, Xie J, Hou P, Chen N, Zhang H, Wyatt RJ, Novak J, Julian BA, Feehally J, Stengel B, Cusi D, Lifton RP, Gharavi AG (2014) Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet 46:1187\u20131196","journal-title":"Nat Genet"},{"key":"4475_CR75","first-page":"295","volume":"73","author":"M Sato","year":"1988","unstructured":"Sato M, Kojima H, Takayama K, Koshikawa S (1988) Glomerular deposition of food antigens in IgA nephropathy. Clin Exp Immunol 73:295\u2013299","journal-title":"Clin Exp Immunol"},{"key":"4475_CR76","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1093\/ndt\/gfp133","volume":"24","author":"HK Smerud","year":"2009","unstructured":"Smerud HK, Fellstrom B, Hallgren R, Osagie S, Venge P, Kristjansson G (2009) Gluten sensitivity in patients with IgA nephropathy. Nephrol Dial Transplant 24:2476\u20132481","journal-title":"Nephrol Dial Transplant"},{"key":"4475_CR77","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1111\/j.1572-0241.2002.06025.x","volume":"97","author":"P Collin","year":"2002","unstructured":"Collin P, Syrjanen J, Partanen J, Pasternack A, Kaukinen K, Mustonen J (2002) Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol 97:2572\u20132576","journal-title":"Am J Gastroenterol"},{"key":"4475_CR78","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ki.2015.94","volume":"88","author":"C Papista","year":"2015","unstructured":"Papista C, Lechner S, Ben Mkaddem S, LeStang MB, Abbad L, Bex-Coudrat J, Pillebout E, Chemouny JM, Jablonski M, Flamant M, Daugas E, Vrtovsnik F, Yiangou M, Berthelot L, Monteiro RC (2015) Gluten exacerbates IgA nephropathy in humanized mice through gliadin\u2013CD89 interaction. Kidney Int 88:276\u2013285","journal-title":"Kidney Int"},{"key":"4475_CR79","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1681\/ASN.V210s173","volume":"2","author":"R Coppo","year":"1992","unstructured":"Coppo R, Amore A, Roccatello D (1992) Dietary antigens and primary immunoglobulin a nephropathy. J Am Soc Nephrol 2:S173\u2013S180","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR80","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0140-6736(17)30550-0","volume":"389","author":"BC Fellstrom","year":"2017","unstructured":"Fellstrom BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, Sorensen SS, Tesar V, Del Vecchio L, NEFIGAN Trial Investigators (2017) Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Lancet 389:2117\u20132127","journal-title":"Lancet"},{"key":"4475_CR81","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/jpc.14259","volume":"54","author":"O Venettacci","year":"2018","unstructured":"Venettacci O, Larkins N, Willis F (2018) Childhood IgA nephropathy successfully treated with targeted-release budesonide: a case report. J Paediatr Child Health 54:1403","journal-title":"J Paediatr Child Health"},{"key":"4475_CR82","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1056\/NEJMoa1415463","volume":"373","author":"T Rauen","year":"2015","unstructured":"Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JF, Hilgers RD, Floege J, STOP-IgAN Investigators (2015) Intensive supportive care plus immunosuppression in IgA nephropathy. N Engl J Med 373:2225\u20132236","journal-title":"N Engl J Med"},{"key":"4475_CR83","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2017.9362","volume":"318","author":"J Lv","year":"2017","unstructured":"Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang HY, Perkovic V, TESTING Study Group (2017) Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA 318:432\u2013442","journal-title":"JAMA"},{"key":"4475_CR84","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1681\/ASN.2013080905","volume":"25","author":"A Ramezani","year":"2014","unstructured":"Ramezani A, Raj DS (2014) The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 25:657\u2013670","journal-title":"J Am Soc Nephrol"},{"key":"4475_CR85","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/nu7031565","volume":"7","author":"J Hollon","year":"2015","unstructured":"Hollon J, Puppa EL, Greenwald B, Goldberg E, Guerrerio A, Fasano A (2015) Effect of gliadin on permeability of intestinal biopsy explants from celiac disease patients and patients with non-celiac gluten sensitivity. Nutrients 7:1565\u20131576","journal-title":"Nutrients"},{"key":"4475_CR86","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1093\/ndt\/gfm781","volume":"23","author":"W Qin","year":"2008","unstructured":"Qin W, Zhong X, Fan JM, Zhang YJ, Liu XR, Ma XY (2008) External suppression causes the low expression of the Cosmc gene in IgA nephropathy. Nephrol Dial Transplant 23:1608\u20131614","journal-title":"Nephrol Dial Transplant"},{"key":"4475_CR87","doi-asserted-by":"crossref","first-page":"e99006","DOI":"10.1371\/journal.pone.0099006","volume":"9","author":"M De Angelis","year":"2014","unstructured":"De Angelis M, Montemurno E, Piccolo M, Vannini L, Lauriero G, Maranzano V, Gozzi G, Serrazanetti D, Dalfino G, Gobbetti M, Gesualdo L (2014) Microbiota and metabolome associated with immunoglobulin a nephropathy (IgAN). PLoS One 9:e99006","journal-title":"PLoS One"},{"key":"4475_CR88","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ndt\/gfy323","volume":"34","author":"JM Chemouny","year":"2019","unstructured":"Chemouny JM, Gleeson PJ, Abbad L, Lauriero G, Boedec E, Le Roux K, Monot C, Bredel M, Bex-Coudrat J, Sannier A, Daugas E, Vrtovsnik F, Gesualdo L, Leclerc M, Berthelot L, Ben Mkaddem S, Lepage P, Monteiro RC (2019) Modulation of the microbiota by oral antibiotics treats immunoglobulin a nephropathy in humanized mice. Nephrol Dial Transplant 34:1135\u20131144","journal-title":"Nephrol Dial Transplant"},{"key":"4475_CR89","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1056\/NEJMc1803103","volume":"378","author":"FE Juul","year":"2018","unstructured":"Juul FE, Garborg K, Bretthauer M, Skudal H, Oines MN, Wiig H, Rose O, Seip B, Lamont JT, Midtvedt T, Valeur J, Kalager M, Holme O, Helsingen L, Loberg M, Adami HO (2018) Fecal microbiota transplantation for primary Clostridium difficile infection. N Engl J Med 378:2535\u20132536","journal-title":"N Engl J Med"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04475-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-020-04475-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-020-04475-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T03:38:23Z","timestamp":1665805103000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-020-04475-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4475"],"URL":"https:\/\/doi.org\/10.1007\/s00467-020-04475-w","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"22 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}